Fig. 3From: Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical modelThe growth of tumor radius R(t) during the administration of anti-PD-1 drug and BRAF/MEK inhibitors. Anti-PD-1 is administered at rate γ A =0.3×10−9 g/cm3·day and BRAF/MEK inhibitor is administered at rate γ B =0.5×10−9 g/cm3·day. All other parameter values are the same as in Tables 2 and 3 Back to article page